Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 USD | +1.44% | -4.73% | -21.30% |
May. 10 | Tranche Update on Cumberland Pharmaceuticals Inc.'s Equity Buyback Plan announced on May 13, 2010. | CI |
May. 07 | Transcript : Cumberland Pharmaceuticals Inc., Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
Sales 2022 | 42.01M | Sales 2023 | 39.55M | Capitalization | 26.7M |
---|---|---|---|---|---|
Net income 2022 | -5M | Net income 2023 | -6M | EV / Sales 2022 | 0.8 x |
Net Debt 2022 | 1.2M | Net Debt 2023 | 107K | EV / Sales 2023 | 0.68 x |
P/E ratio 2022 |
-5.88
x | P/E ratio 2023 |
-4.07
x | Employees | 91 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 55.99% |
Latest transcript on Cumberland Pharmaceuticals Inc.
1 day | +1.44% | ||
1 week | -4.73% | ||
Current month | -4.73% | ||
1 month | -8.44% | ||
3 months | -30.37% | ||
6 months | -16.57% | ||
Current year | -21.30% |
Managers | Title | Age | Since |
---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 65 | 99-01-06 |
John Hamm
DFI | Director of Finance/CFO | 67 | 18-12-31 |
James Herman
CMP | Compliance Officer | 67 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Brown
BRD | Director/Board Member | 59 | 22-07-14 |
A. Kazimi
CEO | Chief Executive Officer | 65 | 99-01-06 |
Ken Krogulski
BRD | Director/Board Member | 66 | 17-01-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 1.41 | +1.44% | 2 171 |
24-06-07 | 1.39 | -2.80% | 1,841 |
24-06-06 | 1.43 | -0.69% | 273 |
24-06-05 | 1.44 | -0.70% | 9,563 |
24-06-04 | 1.45 | -2.02% | 7,803 |
Delayed Quote Nasdaq, June 10, 2024 at 09:30 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-21.30% | 19.73M | |
+20.14% | 43.3B | |
+23.67% | 22.22B | |
+16.52% | 15.43B | |
+23.10% | 14.48B | |
+57.58% | 12.72B | |
-0.05% | 6.79B | |
-10.69% | 6.71B | |
-8.87% | 5.73B | |
+14.68% | 5.5B |
- Stock Market
- Equities
- CPIX Stock